| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Pediatric | 9 | 2023 | 1775 | 1.790 |
Why?
|
| Bell Palsy | 2 | 2021 | 41 | 1.520 |
Why?
|
| Neonatal Abstinence Syndrome | 3 | 2023 | 109 | 1.460 |
Why?
|
| Parenteral Nutrition, Home | 3 | 2018 | 35 | 1.420 |
Why?
|
| International Normalized Ratio | 12 | 2016 | 367 | 1.300 |
Why?
|
| Catheter-Related Infections | 4 | 2018 | 252 | 1.180 |
Why?
|
| Homosexuality, Female | 6 | 2019 | 157 | 1.140 |
Why?
|
| Bisexuality | 7 | 2019 | 270 | 1.130 |
Why?
|
| Warfarin | 15 | 2016 | 1496 | 1.110 |
Why?
|
| Accidents, Occupational | 4 | 2012 | 251 | 1.010 |
Why?
|
| Anticoagulants | 19 | 2016 | 4599 | 0.920 |
Why?
|
| Quality Indicators, Health Care | 4 | 2021 | 1831 | 0.850 |
Why?
|
| Body Fluids | 1 | 2024 | 319 | 0.830 |
Why?
|
| Colorectal Neoplasms | 8 | 2022 | 6773 | 0.750 |
Why?
|
| Naloxone | 2 | 2013 | 367 | 0.720 |
Why?
|
| Hospitals, Public | 1 | 2021 | 207 | 0.720 |
Why?
|
| Vaccines | 3 | 2022 | 822 | 0.690 |
Why?
|
| Malpractice | 2 | 2023 | 572 | 0.650 |
Why?
|
| Natural Language Processing | 3 | 2023 | 1041 | 0.650 |
Why?
|
| Sexual Behavior | 10 | 2021 | 2057 | 0.640 |
Why?
|
| Narcotic Antagonists | 2 | 2013 | 562 | 0.630 |
Why?
|
| Hospital Administrators | 1 | 2018 | 57 | 0.610 |
Why?
|
| Drug Interactions | 3 | 2020 | 1460 | 0.600 |
Why?
|
| Occupational Diseases | 3 | 2010 | 1471 | 0.580 |
Why?
|
| Workers' Compensation | 5 | 2014 | 152 | 0.560 |
Why?
|
| Survivors | 8 | 2022 | 2291 | 0.550 |
Why?
|
| Health Services | 1 | 2021 | 758 | 0.540 |
Why?
|
| Risk Management | 1 | 2019 | 571 | 0.540 |
Why?
|
| Patient Readmission | 5 | 2022 | 3114 | 0.530 |
Why?
|
| Hospital Information Systems | 1 | 2018 | 395 | 0.520 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 465 | 0.490 |
Why?
|
| BCG Vaccine | 3 | 2022 | 369 | 0.480 |
Why?
|
| Drug Monitoring | 3 | 2015 | 956 | 0.450 |
Why?
|
| Inpatients | 2 | 2023 | 2518 | 0.430 |
Why?
|
| Population Surveillance | 8 | 2018 | 2616 | 0.430 |
Why?
|
| Medication Errors | 2 | 2018 | 798 | 0.430 |
Why?
|
| Data Collection | 5 | 2014 | 3341 | 0.430 |
Why?
|
| Humans | 137 | 2024 | 744343 | 0.430 |
Why?
|
| Hospitalization | 6 | 2023 | 10262 | 0.430 |
Why?
|
| Medical Order Entry Systems | 1 | 2018 | 545 | 0.430 |
Why?
|
| Patient Discharge | 2 | 2022 | 3313 | 0.420 |
Why?
|
| Space-Time Clustering | 2 | 2009 | 49 | 0.400 |
Why?
|
| Opioid-Related Disorders | 3 | 2023 | 2065 | 0.400 |
Why?
|
| Quality Improvement | 9 | 2018 | 3749 | 0.390 |
Why?
|
| Hospital Costs | 1 | 2018 | 985 | 0.390 |
Why?
|
| Heterosexuality | 3 | 2020 | 276 | 0.380 |
Why?
|
| Homosexuality | 1 | 2011 | 262 | 0.370 |
Why?
|
| Infant, Newborn | 22 | 2023 | 25625 | 0.370 |
Why?
|
| Health Education | 2 | 2017 | 1056 | 0.370 |
Why?
|
| Narcotics | 1 | 2012 | 343 | 0.360 |
Why?
|
| Methadone | 1 | 2012 | 306 | 0.360 |
Why?
|
| United States | 34 | 2023 | 69872 | 0.360 |
Why?
|
| Atrial Fibrillation | 10 | 2016 | 5034 | 0.360 |
Why?
|
| Disease Outbreaks | 6 | 2014 | 1772 | 0.350 |
Why?
|
| Bacteremia | 4 | 2021 | 962 | 0.340 |
Why?
|
| Turkey | 2 | 2021 | 237 | 0.340 |
Why?
|
| Homosexuality, Male | 2 | 2014 | 1240 | 0.330 |
Why?
|
| Databases, Factual | 6 | 2018 | 7729 | 0.330 |
Why?
|
| United States Department of Veterans Affairs | 7 | 2016 | 875 | 0.330 |
Why?
|
| Blood Coagulation | 6 | 2016 | 1127 | 0.320 |
Why?
|
| Communication | 3 | 2020 | 3749 | 0.310 |
Why?
|
| Topography, Medical | 1 | 2007 | 37 | 0.310 |
Why?
|
| Hospitals | 5 | 2023 | 3952 | 0.310 |
Why?
|
| Hemorrhage | 9 | 2015 | 3461 | 0.310 |
Why?
|
| Child | 31 | 2023 | 77709 | 0.300 |
Why?
|
| Judgment | 1 | 2010 | 281 | 0.300 |
Why?
|
| Female | 84 | 2024 | 380194 | 0.300 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 2212 | 0.290 |
Why?
|
| Cytokines | 8 | 2023 | 7322 | 0.290 |
Why?
|
| Infant | 23 | 2023 | 35136 | 0.280 |
Why?
|
| Analgesics, Opioid | 4 | 2023 | 3674 | 0.270 |
Why?
|
| Electronic Health Records | 3 | 2022 | 4468 | 0.270 |
Why?
|
| Male | 73 | 2022 | 350118 | 0.270 |
Why?
|
| Sentinel Surveillance | 1 | 2007 | 281 | 0.270 |
Why?
|
| Health Surveys | 2 | 2014 | 4037 | 0.260 |
Why?
|
| Health Care Costs | 1 | 2018 | 3209 | 0.250 |
Why?
|
| Epidemiologic Measurements | 1 | 2004 | 23 | 0.250 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 2400 | 0.250 |
Why?
|
| Research Design | 3 | 2016 | 5987 | 0.250 |
Why?
|
| Geographic Information Systems | 2 | 2014 | 281 | 0.250 |
Why?
|
| Fetal Blood | 3 | 2021 | 1318 | 0.240 |
Why?
|
| Quality of Life | 6 | 2022 | 12804 | 0.240 |
Why?
|
| Health Behavior | 2 | 2015 | 2636 | 0.240 |
Why?
|
| Adjuvants, Immunologic | 4 | 2022 | 1000 | 0.240 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 5319 | 0.240 |
Why?
|
| Down Syndrome | 3 | 2017 | 880 | 0.230 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 5137 | 0.230 |
Why?
|
| Massachusetts | 10 | 2018 | 8663 | 0.230 |
Why?
|
| Length of Stay | 4 | 2022 | 6309 | 0.220 |
Why?
|
| Aged | 41 | 2022 | 163280 | 0.220 |
Why?
|
| Chemokines | 3 | 2023 | 970 | 0.220 |
Why?
|
| Child, Preschool | 18 | 2023 | 41006 | 0.220 |
Why?
|
| Minority Groups | 4 | 2015 | 1223 | 0.220 |
Why?
|
| Patient Education as Topic | 3 | 2019 | 2278 | 0.210 |
Why?
|
| Pressure Ulcer | 1 | 2023 | 155 | 0.210 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 634 | 0.210 |
Why?
|
| Data Interpretation, Statistical | 5 | 2013 | 2716 | 0.210 |
Why?
|
| Health Status Disparities | 1 | 2014 | 1797 | 0.210 |
Why?
|
| Streptococcal Infections | 2 | 2018 | 638 | 0.210 |
Why?
|
| Immunity, Innate | 4 | 2021 | 2958 | 0.210 |
Why?
|
| Aluminum Hydroxide | 1 | 2022 | 58 | 0.210 |
Why?
|
| Physicians | 2 | 2019 | 4567 | 0.210 |
Why?
|
| United States Agency for Healthcare Research and Quality | 1 | 2021 | 92 | 0.200 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2020 | 199 | 0.200 |
Why?
|
| Insurance | 1 | 2023 | 111 | 0.200 |
Why?
|
| Monocytes | 2 | 2021 | 2596 | 0.200 |
Why?
|
| Cluster Analysis | 2 | 2005 | 2715 | 0.200 |
Why?
|
| Influenza, Human | 3 | 2023 | 1479 | 0.200 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2023 | 139 | 0.200 |
Why?
|
| Breast Neoplasms | 7 | 2018 | 20822 | 0.190 |
Why?
|
| Sports Equipment | 1 | 2020 | 23 | 0.190 |
Why?
|
| Incidence | 9 | 2023 | 20947 | 0.190 |
Why?
|
| Electronics | 1 | 2022 | 322 | 0.190 |
Why?
|
| Time | 1 | 2022 | 542 | 0.190 |
Why?
|
| Telemedicine | 1 | 2018 | 2872 | 0.190 |
Why?
|
| Accidents, Home | 1 | 2020 | 75 | 0.190 |
Why?
|
| Acyclovir | 1 | 2021 | 272 | 0.190 |
Why?
|
| Survival Rate | 2 | 2013 | 12788 | 0.180 |
Why?
|
| Venous Thromboembolism | 3 | 2014 | 1671 | 0.180 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 547 | 0.180 |
Why?
|
| Middle Aged | 42 | 2020 | 213383 | 0.180 |
Why?
|
| Defensive Medicine | 1 | 2019 | 48 | 0.180 |
Why?
|
| Acute-Phase Proteins | 1 | 2020 | 262 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 1836 | 0.170 |
Why?
|
| Models, Statistical | 6 | 2017 | 5102 | 0.170 |
Why?
|
| Adenosine Deaminase | 1 | 2021 | 241 | 0.170 |
Why?
|
| Toll-Like Receptors | 2 | 2019 | 592 | 0.160 |
Why?
|
| Young Adult | 21 | 2022 | 56430 | 0.160 |
Why?
|
| Creatinine | 2 | 2022 | 1919 | 0.160 |
Why?
|
| Microbial Viability | 1 | 2020 | 234 | 0.160 |
Why?
|
| Troponin | 1 | 2022 | 524 | 0.160 |
Why?
|
| Retrospective Studies | 20 | 2023 | 77449 | 0.160 |
Why?
|
| Hemophilia A | 1 | 2021 | 351 | 0.160 |
Why?
|
| Chorioamnionitis | 1 | 2019 | 155 | 0.160 |
Why?
|
| Computer Simulation | 5 | 2013 | 6196 | 0.160 |
Why?
|
| Adolescent | 26 | 2022 | 85781 | 0.160 |
Why?
|
| Liability, Legal | 1 | 2019 | 213 | 0.160 |
Why?
|
| Cathelicidins | 1 | 2018 | 80 | 0.160 |
Why?
|
| Thromboembolism | 2 | 2015 | 986 | 0.160 |
Why?
|
| Child Development | 2 | 2020 | 2223 | 0.160 |
Why?
|
| RNA, Bacterial | 1 | 2020 | 390 | 0.160 |
Why?
|
| Disabled Persons | 1 | 2008 | 1212 | 0.160 |
Why?
|
| Plasma | 1 | 2021 | 575 | 0.150 |
Why?
|
| Italy | 1 | 2019 | 832 | 0.150 |
Why?
|
| Adult | 38 | 2021 | 214055 | 0.150 |
Why?
|
| Breast Diseases | 1 | 2020 | 443 | 0.150 |
Why?
|
| Complement System Proteins | 1 | 2020 | 795 | 0.150 |
Why?
|
| Calcinosis | 2 | 2017 | 1499 | 0.150 |
Why?
|
| Mannose-Binding Lectin | 1 | 2018 | 150 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2020 | 881 | 0.150 |
Why?
|
| Reminder Systems | 1 | 2020 | 371 | 0.150 |
Why?
|
| Cross Infection | 2 | 2017 | 1416 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 820 | 0.150 |
Why?
|
| Abscess | 1 | 2020 | 607 | 0.140 |
Why?
|
| Family | 2 | 2018 | 3147 | 0.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2013 | 2737 | 0.140 |
Why?
|
| Eustachian Tube | 1 | 2017 | 91 | 0.140 |
Why?
|
| Epidemiologic Methods | 2 | 2013 | 1364 | 0.140 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2017 | 90 | 0.140 |
Why?
|
| Neoplasms | 4 | 2020 | 21683 | 0.140 |
Why?
|
| HIV Seropositivity | 1 | 2022 | 971 | 0.140 |
Why?
|
| Stroke | 6 | 2016 | 9981 | 0.140 |
Why?
|
| Pharyngitis | 1 | 2018 | 215 | 0.140 |
Why?
|
| Perception | 2 | 2020 | 1198 | 0.140 |
Why?
|
| Quality of Health Care | 3 | 2020 | 4371 | 0.140 |
Why?
|
| Computer Security | 1 | 2018 | 262 | 0.140 |
Why?
|
| Administration, Oral | 7 | 2011 | 3913 | 0.130 |
Why?
|
| Videoconferencing | 1 | 2018 | 195 | 0.130 |
Why?
|
| Ear Diseases | 1 | 2017 | 170 | 0.130 |
Why?
|
| Employee Performance Appraisal | 1 | 2016 | 87 | 0.130 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2017 | 172 | 0.130 |
Why?
|
| HIV Infections | 5 | 2023 | 16718 | 0.130 |
Why?
|
| Parents | 3 | 2017 | 3407 | 0.130 |
Why?
|
| Cyclic AMP | 1 | 2019 | 1472 | 0.130 |
Why?
|
| Mandibular Fractures | 1 | 2016 | 73 | 0.130 |
Why?
|
| Phenotype | 2 | 2024 | 16365 | 0.130 |
Why?
|
| Time Factors | 10 | 2021 | 40075 | 0.130 |
Why?
|
| Vaccines, Conjugate | 1 | 2017 | 333 | 0.130 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 151 | 0.130 |
Why?
|
| Incidental Findings | 2 | 2017 | 689 | 0.130 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 3158 | 0.130 |
Why?
|
| Immune System | 1 | 2020 | 805 | 0.130 |
Why?
|
| Parotid Diseases | 1 | 2014 | 46 | 0.130 |
Why?
|
| Myocarditis | 1 | 2022 | 771 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2022 | 13033 | 0.120 |
Why?
|
| Colony Count, Microbial | 1 | 2015 | 331 | 0.120 |
Why?
|
| Short Bowel Syndrome | 1 | 2018 | 345 | 0.120 |
Why?
|
| Risk Factors | 14 | 2022 | 72290 | 0.120 |
Why?
|
| Maternal Health Services | 1 | 2019 | 455 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2020 | 2453 | 0.120 |
Why?
|
| Mandatory Reporting | 1 | 2015 | 121 | 0.120 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 1681 | 0.120 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 3396 | 0.120 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2017 | 780 | 0.120 |
Why?
|
| Alkaline Phosphatase | 1 | 2017 | 865 | 0.120 |
Why?
|
| RNA, Viral | 1 | 2022 | 2902 | 0.120 |
Why?
|
| Human Rights Abuses | 1 | 2013 | 31 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1676 | 0.120 |
Why?
|
| Thyroid Diseases | 1 | 2017 | 379 | 0.110 |
Why?
|
| Parenteral Nutrition | 1 | 2018 | 650 | 0.110 |
Why?
|
| Morphine | 1 | 2018 | 657 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 514 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 738 | 0.110 |
Why?
|
| Pneumococcal Vaccines | 1 | 2017 | 391 | 0.110 |
Why?
|
| Prospective Studies | 10 | 2022 | 53288 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 530 | 0.110 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 2216 | 0.110 |
Why?
|
| Amputation, Traumatic | 1 | 2014 | 123 | 0.110 |
Why?
|
| Birth Weight | 1 | 2021 | 2069 | 0.110 |
Why?
|
| Aged, 80 and over | 16 | 2017 | 57776 | 0.110 |
Why?
|
| International Cooperation | 1 | 2019 | 1420 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1584 | 0.110 |
Why?
|
| Triiodobenzoic Acids | 2 | 2010 | 124 | 0.110 |
Why?
|
| Pediatric Nursing | 1 | 2014 | 103 | 0.110 |
Why?
|
| Infant, Premature | 2 | 2019 | 2044 | 0.110 |
Why?
|
| Genetic Counseling | 1 | 2016 | 600 | 0.110 |
Why?
|
| Registries | 5 | 2020 | 8089 | 0.110 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 4665 | 0.110 |
Why?
|
| Liver Cirrhosis | 2 | 2013 | 1863 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 20129 | 0.100 |
Why?
|
| Child, Hospitalized | 1 | 2014 | 174 | 0.100 |
Why?
|
| Prenatal Care | 1 | 2019 | 1092 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2020 | 1401 | 0.100 |
Why?
|
| Insurance, Disability | 1 | 2012 | 26 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2017 | 658 | 0.100 |
Why?
|
| Hospitals, Veterans | 2 | 2011 | 404 | 0.100 |
Why?
|
| Harm Reduction | 1 | 2013 | 129 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2018 | 711 | 0.100 |
Why?
|
| Population Dynamics | 1 | 2013 | 302 | 0.100 |
Why?
|
| Social Security | 1 | 2012 | 101 | 0.100 |
Why?
|
| Health Status | 4 | 2015 | 4034 | 0.100 |
Why?
|
| Allied Health Personnel | 1 | 2013 | 162 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 941 | 0.100 |
Why?
|
| Disease Progression | 3 | 2024 | 13284 | 0.100 |
Why?
|
| Leukocytes | 1 | 2019 | 2043 | 0.100 |
Why?
|
| Pharyngeal Muscles | 1 | 2011 | 77 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 417 | 0.100 |
Why?
|
| Administration, Intranasal | 1 | 2012 | 446 | 0.100 |
Why?
|
| Prevalence | 6 | 2020 | 15226 | 0.100 |
Why?
|
| Resilience, Psychological | 1 | 2018 | 676 | 0.100 |
Why?
|
| Homicide | 1 | 2013 | 287 | 0.090 |
Why?
|
| Heart Defects, Congenital | 2 | 2018 | 4584 | 0.090 |
Why?
|
| Risk Adjustment | 2 | 2014 | 594 | 0.090 |
Why?
|
| Stomatitis | 1 | 2013 | 269 | 0.090 |
Why?
|
| Child Health Services | 1 | 2016 | 667 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1799 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1889 | 0.090 |
Why?
|
| Gambia | 2 | 2021 | 98 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 1677 | 0.090 |
Why?
|
| Vaccination | 1 | 2022 | 3278 | 0.090 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2011 | 187 | 0.090 |
Why?
|
| Reproducibility of Results | 8 | 2015 | 19905 | 0.090 |
Why?
|
| Tonsillar Neoplasms | 1 | 2010 | 51 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2725 | 0.090 |
Why?
|
| Psychosocial Deprivation | 1 | 2010 | 99 | 0.090 |
Why?
|
| California | 1 | 2014 | 1402 | 0.090 |
Why?
|
| Reference Values | 3 | 2012 | 4982 | 0.090 |
Why?
|
| Radiotherapy, Conformal | 1 | 2013 | 548 | 0.090 |
Why?
|
| Rural Population | 2 | 2019 | 2210 | 0.090 |
Why?
|
| Palatine Tonsil | 1 | 2010 | 193 | 0.090 |
Why?
|
| Synovitis | 1 | 2011 | 209 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13102 | 0.090 |
Why?
|
| Cohort Studies | 7 | 2023 | 40561 | 0.090 |
Why?
|
| Tuberculosis | 1 | 2022 | 1912 | 0.090 |
Why?
|
| Minnesota | 1 | 2010 | 344 | 0.090 |
Why?
|
| Pandemics | 4 | 2022 | 8388 | 0.080 |
Why?
|
| Operating Rooms | 1 | 2016 | 817 | 0.080 |
Why?
|
| Diarrhea | 1 | 2016 | 1348 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.080 |
Why?
|
| Checklist | 1 | 2016 | 833 | 0.080 |
Why?
|
| Celiac Disease | 1 | 2016 | 785 | 0.080 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2012 | 427 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 961 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2013 | 3327 | 0.080 |
Why?
|
| Opiate Substitution Treatment | 1 | 2012 | 404 | 0.080 |
Why?
|
| Nipples | 1 | 2010 | 219 | 0.080 |
Why?
|
| AIDS Serodiagnosis | 1 | 2009 | 184 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 39050 | 0.080 |
Why?
|
| Amyloidosis, Familial | 1 | 2007 | 13 | 0.080 |
Why?
|
| Pediatrics | 3 | 2020 | 3475 | 0.080 |
Why?
|
| Proteomics | 4 | 2022 | 3638 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 816 | 0.080 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2013 | 477 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 2 | 2011 | 933 | 0.080 |
Why?
|
| Parental Notification | 1 | 2007 | 12 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2012 | 632 | 0.080 |
Why?
|
| Xylitol | 1 | 2007 | 23 | 0.070 |
Why?
|
| Medical Errors | 1 | 2016 | 1297 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 4 | 2021 | 7181 | 0.070 |
Why?
|
| Veterans Health | 3 | 2015 | 216 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2266 | 0.070 |
Why?
|
| Violence | 1 | 2013 | 909 | 0.070 |
Why?
|
| Rhode Island | 1 | 2008 | 347 | 0.070 |
Why?
|
| Curriculum | 2 | 2013 | 3605 | 0.070 |
Why?
|
| Pilot Projects | 4 | 2018 | 8324 | 0.070 |
Why?
|
| Critical Care | 2 | 2017 | 2647 | 0.070 |
Why?
|
| Nepal | 2 | 2019 | 295 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2012 | 2421 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3218 | 0.070 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2007 | 277 | 0.070 |
Why?
|
| Censuses | 1 | 2008 | 200 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 421 | 0.070 |
Why?
|
| Medical Record Linkage | 1 | 2008 | 284 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2017 | 9146 | 0.070 |
Why?
|
| Sexuality | 1 | 2008 | 174 | 0.070 |
Why?
|
| Eligibility Determination | 1 | 2010 | 403 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 15540 | 0.070 |
Why?
|
| Age Factors | 6 | 2021 | 18370 | 0.070 |
Why?
|
| Maps as Topic | 1 | 2005 | 17 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2013 | 4034 | 0.070 |
Why?
|
| Counseling | 1 | 2014 | 1523 | 0.070 |
Why?
|
| Selection Bias | 1 | 2008 | 371 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2013 | 1180 | 0.070 |
Why?
|
| Prescription Drugs | 1 | 2013 | 595 | 0.070 |
Why?
|
| Demography | 2 | 2015 | 1656 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2014 | 1253 | 0.070 |
Why?
|
| Leukemia | 1 | 2014 | 1511 | 0.070 |
Why?
|
| Deglutition Disorders | 1 | 2011 | 605 | 0.070 |
Why?
|
| Gestational Age | 3 | 2019 | 3493 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1738 | 0.060 |
Why?
|
| Spouses | 1 | 2008 | 286 | 0.060 |
Why?
|
| Image Enhancement | 2 | 2013 | 2921 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2016 | 1643 | 0.060 |
Why?
|
| Evidence-Based Practice | 1 | 2009 | 500 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2021 | 3752 | 0.060 |
Why?
|
| Denmark | 2 | 2020 | 738 | 0.060 |
Why?
|
| Otitis Media | 1 | 2007 | 277 | 0.060 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 25043 | 0.060 |
Why?
|
| Models, Biological | 2 | 2013 | 9583 | 0.060 |
Why?
|
| Substance-Related Disorders | 2 | 2013 | 4258 | 0.060 |
Why?
|
| HIV-1 | 1 | 2022 | 6939 | 0.060 |
Why?
|
| Sweetening Agents | 1 | 2007 | 296 | 0.060 |
Why?
|
| Algorithms | 4 | 2013 | 13881 | 0.060 |
Why?
|
| Medication Adherence | 2 | 2013 | 2063 | 0.060 |
Why?
|
| New York | 2 | 2018 | 886 | 0.060 |
Why?
|
| Medicare | 1 | 2021 | 6566 | 0.060 |
Why?
|
| Confidentiality | 1 | 2007 | 612 | 0.060 |
Why?
|
| Geography | 1 | 2005 | 669 | 0.060 |
Why?
|
| Appendicitis | 1 | 2009 | 645 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2004 | 403 | 0.050 |
Why?
|
| Sepsis | 1 | 2017 | 2593 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2015 | 9849 | 0.050 |
Why?
|
| Dementia | 1 | 2016 | 2518 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 2924 | 0.050 |
Why?
|
| Aging | 2 | 2012 | 8664 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 3843 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 579 | 0.050 |
Why?
|
| Sensitivity and Specificity | 6 | 2013 | 14722 | 0.050 |
Why?
|
| Clinical Clerkship | 1 | 2007 | 532 | 0.050 |
Why?
|
| Radiation Oncology | 1 | 2007 | 555 | 0.050 |
Why?
|
| Japan | 2 | 2020 | 1360 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2016 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 2408 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2023 | 389 | 0.050 |
Why?
|
| Mammography | 2 | 2010 | 2476 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 3537 | 0.050 |
Why?
|
| Ecchymosis | 1 | 2020 | 32 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3265 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3176 | 0.050 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 1222 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15076 | 0.050 |
Why?
|
| Deductibles and Coinsurance | 1 | 2023 | 316 | 0.050 |
Why?
|
| Educational Measurement | 1 | 2007 | 1210 | 0.050 |
Why?
|
| Bulgaria | 1 | 2020 | 25 | 0.050 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 13989 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 2645 | 0.050 |
Why?
|
| Nursing Care | 1 | 2020 | 74 | 0.040 |
Why?
|
| Contrast Media | 2 | 2010 | 5300 | 0.040 |
Why?
|
| Papua New Guinea | 1 | 2019 | 42 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2020 | 150 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2008 | 1151 | 0.040 |
Why?
|
| Diglycerides | 1 | 2019 | 176 | 0.040 |
Why?
|
| Lacerations | 1 | 2020 | 144 | 0.040 |
Why?
|
| Georgia | 1 | 2018 | 186 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 7279 | 0.040 |
Why?
|
| Pregnancy | 4 | 2023 | 29144 | 0.040 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 12354 | 0.040 |
Why?
|
| Fracture Fixation | 1 | 2020 | 354 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2010 | 3589 | 0.040 |
Why?
|
| Staphylococcus epidermidis | 1 | 2018 | 117 | 0.040 |
Why?
|
| Immunization | 1 | 2022 | 1256 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 6622 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2007 | 1239 | 0.040 |
Why?
|
| Risk | 2 | 2011 | 9687 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 168757 | 0.040 |
Why?
|
| Rosaniline Dyes | 1 | 2017 | 51 | 0.040 |
Why?
|
| Mental Health | 3 | 2020 | 3019 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2023 | 944 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 541 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 2734 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2023 | 899 | 0.040 |
Why?
|
| Salmonella | 1 | 2017 | 129 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2020 | 476 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2017 | 111 | 0.030 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 286 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2016 | 23338 | 0.030 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2018 | 362 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2013 | 21746 | 0.030 |
Why?
|
| Liver | 1 | 2011 | 7474 | 0.030 |
Why?
|
| Parturition | 1 | 2019 | 441 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4042 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2020 | 798 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2010 | 1654 | 0.030 |
Why?
|
| Computational Biology | 1 | 2007 | 3521 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2017 | 251 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 469 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 1877 | 0.030 |
Why?
|
| Interdisciplinary Studies | 1 | 2015 | 89 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2008 | 3966 | 0.030 |
Why?
|
| Candida albicans | 1 | 2018 | 394 | 0.030 |
Why?
|
| Comorbidity | 3 | 2014 | 10388 | 0.030 |
Why?
|
| Smoking | 2 | 2011 | 8987 | 0.030 |
Why?
|
| HIV | 1 | 2022 | 1604 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2011 | 35421 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2019 | 568 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1348 | 0.030 |
Why?
|
| Students, Medical | 1 | 2007 | 1862 | 0.030 |
Why?
|
| Anxiety | 2 | 2021 | 4297 | 0.030 |
Why?
|
| Treatment Outcome | 7 | 2015 | 63114 | 0.030 |
Why?
|
| Brain | 2 | 2012 | 26385 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1880 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2014 | 6600 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2019 | 1189 | 0.030 |
Why?
|
| Age Distribution | 2 | 2012 | 2902 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2010 | 2297 | 0.030 |
Why?
|
| Women's Health | 2 | 2015 | 2034 | 0.030 |
Why?
|
| New England | 1 | 2016 | 1022 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 4328 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2016 | 778 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 707 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 1889 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 12959 | 0.030 |
Why?
|
| Phosphates | 1 | 2017 | 786 | 0.030 |
Why?
|
| India | 1 | 2020 | 2197 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2023 | 1715 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 7659 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2017 | 849 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3200 | 0.030 |
Why?
|
| Thyroxine | 1 | 2017 | 667 | 0.030 |
Why?
|
| Normal Distribution | 1 | 2013 | 280 | 0.030 |
Why?
|
| Viral Load | 1 | 2022 | 3299 | 0.030 |
Why?
|
| Colombia | 1 | 2013 | 258 | 0.030 |
Why?
|
| Public Health | 2 | 2018 | 2603 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15519 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1838 | 0.030 |
Why?
|
| Clinical Coding | 1 | 2014 | 171 | 0.030 |
Why?
|
| Mass Screening | 1 | 2008 | 5255 | 0.030 |
Why?
|
| Blood | 1 | 2015 | 598 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 3022 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2019 | 19229 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 2014 | 455 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11727 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 1726 | 0.030 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2011 | 3 | 0.030 |
Why?
|
| Mothers | 1 | 2023 | 2165 | 0.030 |
Why?
|
| New Mexico | 1 | 2012 | 86 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 1978 | 0.030 |
Why?
|
| Residence Characteristics | 2 | 2014 | 2050 | 0.030 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 195 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 4420 | 0.030 |
Why?
|
| Polypharmacy | 1 | 2014 | 294 | 0.020 |
Why?
|
| Veterans | 2 | 2016 | 2519 | 0.020 |
Why?
|
| Libido | 1 | 2011 | 121 | 0.020 |
Why?
|
| Exercise | 2 | 2020 | 5615 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2007 | 3309 | 0.020 |
Why?
|
| Heart Failure | 1 | 2015 | 10900 | 0.020 |
Why?
|
| Coitus | 1 | 2011 | 133 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2014 | 676 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12245 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2017 | 2375 | 0.020 |
Why?
|
| Metabolomics | 1 | 2019 | 1484 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2023 | 3679 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 981 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2015 | 10252 | 0.020 |
Why?
|
| Palpation | 1 | 2010 | 167 | 0.020 |
Why?
|
| Sample Size | 1 | 2013 | 845 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2017 | 1173 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5524 | 0.020 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2011 | 133 | 0.020 |
Why?
|
| Propensity Score | 1 | 2016 | 1781 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 1451 | 0.020 |
Why?
|
| Blood Volume | 1 | 2011 | 565 | 0.020 |
Why?
|
| Bacteria | 1 | 2020 | 2114 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2018 | 4245 | 0.020 |
Why?
|
| Prognosis | 3 | 2015 | 29063 | 0.020 |
Why?
|
| Radiography | 1 | 2020 | 7023 | 0.020 |
Why?
|
| Depression | 2 | 2021 | 7766 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2020 | 1947 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2011 | 392 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2010 | 280 | 0.020 |
Why?
|
| Medical Records | 1 | 2014 | 1413 | 0.020 |
Why?
|
| Social Support | 1 | 2018 | 2118 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2012 | 659 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
| Macroglossia | 1 | 2007 | 11 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
| Absenteeism | 1 | 2009 | 250 | 0.020 |
Why?
|
| Submandibular Gland Diseases | 1 | 2007 | 21 | 0.020 |
Why?
|
| Axilla | 1 | 2010 | 595 | 0.020 |
Why?
|
| Submandibular Gland | 1 | 2007 | 86 | 0.020 |
Why?
|
| Acute Disease | 2 | 2009 | 7149 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 1525 | 0.020 |
Why?
|
| Vitamin K | 1 | 2009 | 295 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1420 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 713 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 3229 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2010 | 1144 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2373 | 0.020 |
Why?
|
| Cicatrix | 1 | 2012 | 764 | 0.020 |
Why?
|
| SEER Program | 1 | 2011 | 1508 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 537 | 0.020 |
Why?
|
| Prejudice | 1 | 2010 | 570 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 981 | 0.020 |
Why?
|
| Brazil | 1 | 2010 | 1270 | 0.020 |
Why?
|
| Joints | 1 | 2007 | 326 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 1025 | 0.020 |
Why?
|
| Arousal | 1 | 2011 | 1165 | 0.020 |
Why?
|
| Asthma | 1 | 2004 | 6011 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 1681 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1915 | 0.020 |
Why?
|
| Social Environment | 1 | 2010 | 1023 | 0.020 |
Why?
|
| Mice | 3 | 2022 | 81183 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 8949 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2004 | 55 | 0.020 |
Why?
|
| Logistic Models | 2 | 2010 | 13408 | 0.020 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2011 | 806 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 21827 | 0.020 |
Why?
|
| Tongue | 1 | 2007 | 406 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 6756 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2576 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 4669 | 0.020 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2007 | 300 | 0.010 |
Why?
|
| Life Style | 1 | 2015 | 3835 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 6038 | 0.010 |
Why?
|
| Gynecology | 1 | 2009 | 513 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2009 | 1063 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1405 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6365 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9438 | 0.010 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 1184 | 0.010 |
Why?
|
| Alcoholism | 1 | 2013 | 1906 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2004 | 340 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3616 | 0.010 |
Why?
|
| Boston | 1 | 2015 | 9313 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3527 | 0.010 |
Why?
|
| Patient Admission | 1 | 2009 | 1380 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 1073 | 0.010 |
Why?
|
| Causality | 1 | 2008 | 1275 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2007 | 2971 | 0.010 |
Why?
|
| Schools | 1 | 2009 | 1433 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6538 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2016 | 4687 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7785 | 0.010 |
Why?
|
| Students | 1 | 2009 | 1654 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 1997 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10180 | 0.010 |
Why?
|
| Haplotypes | 1 | 2004 | 2779 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10943 | 0.010 |
Why?
|
| Diet | 1 | 2015 | 7939 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2007 | 2575 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 4644 | 0.010 |
Why?
|
| Sex Factors | 1 | 2009 | 10397 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 15165 | 0.010 |
Why?
|
| Inflammation | 1 | 2011 | 10638 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 12951 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 5181 | 0.010 |
Why?
|